PAHC NASDAQ
Phibro Animal Health Corporation
1W: -0.8%
1M: +13.3%
3M: +7.3%
YTD: +4.9%
1Y: -4.7%
3Y: +249.1%
5Y: +101.2%
$38.38
-0.65 (-1.67%)
After Hours: $39.50 (+1.12, +2.92%)
Weekly Expected Move ±4.4%
$35
$37
$39
$41
$42
Credit Risk of going bust: higher than 69% of companies Debt: 33.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.83 (down 95%), Phibro Animal Health Corporation would be worth roughly what it owes.
Total debt $788.8M against a stock market value of $1.58B.
Distance to default 3.51 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $378.9M (short-term plus half of long-term), stock volatility 55.3%; Altman Z 3.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $1.83 (down 95%), Phibro Animal Health Corporation would be worth roughly what it owes.
Total debt $788.8M against a stock market value of $1.58B.
Distance to default 3.51 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $378.9M (short-term plus half of long-term), stock volatility 55.3%; Altman Z 3.09. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-04-29
Earliest Filing
2024-10-31
Latest Filing
target: 2
Counterparties (Filed by PAHC)
2 relationshipsCompanies named in PAHC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Zoetis Inc. | ZTS | target | Target of the $350 million cash acquisition for medicated feed additive and water soluble products portfolio. | 2024-10-31 | View |
| Zoetis Inc. | ZTS | target | Target of acquisition for medicated feed additive product portfolio and related assets | 2024-04-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-26 | Earnings Release; Exhibits | View | |
| 2026-07-28 | Other Events; Exhibits | View | |
| 2026-06-26 | Officer/Director Change | View | |
| 2026-05-06 | Earnings Release; Exhibits | View | |
| 2026-05-05 | Other Events; Exhibits | View | |
| 2026-04-30 | Material Agreement; Financial Obligation; Exhibits | Agreement | View |
| 2026-04-27 | Regulation FD; Exhibits | View | |
| 2026-04-14 | Officer/Director Change | View | |
| 2026-02-04 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-03 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-18 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Submission of Matters to a Vote of Security Holders; | View | |
| 2025-11-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-27 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-29 | Other Events; Financial Statements and Exhibits | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-04 | Other Events; Financial Statements and Exhibits | View | |
| 2025-01-23 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR